NVTR - Nuvectra Corporation

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Nuvectra Corporation

5830 Granite Parkway
Suite 1100
Plano, TX 75024
United States
214-474-3103
http://www.nuvectramed.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees197

Key Executives

NameTitlePayExercisedYear Born
Dr. Fred B. Parks Ph.D.Interim Pres, CEO & Director47.5kN/A1947
Ms. Jennifer J. KosharekInterim CFO, VP, Controller & Principal Accounting OfficerN/AN/A1982
Mr. Benjamin TranchinaChief Technology OfficerN/AN/AN/A
Ms. Melissa G. BeareExec. VP, Gen. Counsel & Corp. Sec.N/AN/A1975
Ms. Bonnie SchmidtExec. Director of HRN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

Corporate Governance

Nuvectra Corporation’s ISS Governance QualityScore as of July 29, 2019 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.